Yumanity Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Kineta

13/08/2021 02:50

* Yumanity Therapeutics Inc  YMTX.OQ  reported a quarterly
adjusted loss of $1.03​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 84 cents per share.
* Revenue was $2.11 million​;  analysts expected $2.27 million. 
* Yumanity Therapeutics Inc's reported EPS for the quarter was a
loss of $1.03​.
* The mean earnings estimate of analysts had risen by about 2.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Yumanity Therapeutics Inc shares had fallen by 15.6% this
quarter and lost 42.2% so far this year.
* The company reported a quarterly loss of $10.45 million.
* Wall Street's median 12-month price target for Yumanity
Therapeutics Inc is $36.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 13 at 01:50 a.m.  ​All
figures in US dollars unless otherwise stated